Ana Jagodić | Microbiome dysbiosis | Best Researcher Award

Published on by Environmental Scientists

Dr. Ana Jagodić | Microbiome dysbiosis | Best Researcher Award

Family Medicine Resident, Health Center of Krapina-Zagorje County, Croatia

Ana Jagodić is a dedicated Family Medicine Resident at the Health Centre of Krapina-Zagorje County 🇭🇷. With a focus on community well-being, she integrates clinical knowledge and preventive strategies to combat common diseases in primary care. Her mission revolves around improving healthcare delivery in rural and underserved populations through evidence-based approaches. Ana’s passion lies in promoting proactive health, supporting early interventions, and building sustainable care models to uplift the standard of patient outcomes in everyday family practice. 💉📊

Profile

Google Scholar

🎓 Education

Ana holds a medical degree and is currently pursuing specialization in Family Medicine. Her academic journey has been marked by a growing commitment to research and patient-centered care, with special attention to preventive strategies in primary health. 🏥📚 She continuously updates her skills and applies her knowledge to real-world challenges faced by patients in rural communities.

💼 Experience

As a Family Medicine Resident, Ana has worked closely with diverse patient populations, especially in rural clinics where healthcare access is limited. 🩺🌿 She applies evidence-based practices to address patient needs and has collaborated with professionals in public health to design strategies that improve disease prevention and management in family medicine settings. Her clinical experience is enriched by her teaching role at Fitness Učilište, where she promotes wellness through education. 🧠🏋️‍♀️

🔬 Research Interest

Ana’s primary research focus is on preventive healthcare within family medicine. She is especially interested in disease pathophysiology and how early interventions can significantly reduce the burden of chronic conditions. 👩‍⚕️💡 Her future project targets improving outcomes in elderly populations through EU-funded preventive healthcare strategies. Ana’s broader vision is to bridge the gap between clinical care and prevention, ensuring every patient benefits from timely and scientifically grounded interventions. 👵👴💊

🏆 Award

Ana is a nominee for the Best Researcher Award 🥇 in recognition of her commitment to improving preventive medicine in rural settings. Her work champions healthcare equality and evidence-driven care delivery. Her nomination reflects her growing impact in the field of family medicine and her aspiration to enhance care for marginalized populations. 🏅🌍

📚 Publication

“Nanomedicine in Neuroprotection, Neuroregeneration, and Blood–Brain Barrier Modulation: A Narrative Review”. 🧠🔬
👉 Read Publication | Pharmaceuticals, 2023
📈 Cited by 5 articles

🏁 Conclusion

Ana Jagodić is a promising early-career researcher with a clear vision for impactful work in preventive healthcare and rural medicine. Her strong clinical commitment and upcoming project ideas suggest potential for future leadership in public health research. However, at present, her profile may better align with “Emerging Researcher” or “Young Research Talent” categories rather than the Best Researcher Award, which typically recognizes researchers with an extensive and impactful research portfolio.

Hayriye Kırkoyun Uysal | Medical Microbiology | Best Researcher Award

Published on by Environmental Scientists

Assoc. Prof. Dr. Hayriye Kırkoyun Uysal | Medical Microbiology | Best Researcher Award

Assoc.Prof.Dr./Academician, Istanbul University Istanbul Medical Faculty, Turkey 📝

Dr. Hayriye Kırkoyun Uysal is a distinguished researcher and academic affiliated with Istanbul Medical Faculty, Istanbul University, Turkey. Her expertise spans microbiology, infectious diseases, and molecular diagnostics. With numerous peer-reviewed publications, she has made significant contributions to virology, epidemiology, and diagnostic innovations. Dr. Uysal is actively involved in groundbreaking studies on SARS-CoV-2, Epstein-Barr virus, and other infectious agents, shaping the future of clinical microbiology.

Profile

Orcid

Education 🎓

Dr. Uysal completed her medical education at Istanbul Medical Faculty, Istanbul University, Turkey, where she gained extensive knowledge in clinical microbiology and infectious diseases. Her academic journey reflects a strong foundation in diagnostic methodologies, virology, and immunology, preparing her for a career at the intersection of research and clinical applications.

Professional Experience 💼

Dr. Hayriye Kırkoyun Uysal is currently employed at Istanbul Medical Faculty, Istanbul University, where she is engaged in clinical research, diagnostic microbiology, and infectious disease investigations. She collaborates with multidisciplinary teams to advance diagnostic technologies and public health interventions. Her work includes pioneering research in molecular virology and serological diagnostics.

Research Interests 🔬

Dr. Hayriye Kırkoyun Uysal’s research focuses on virology, molecular diagnostics, and infectious diseases, with a strong emphasis on improving diagnostic methodologies and understanding viral pathogenesis. She is particularly interested in congenital cytomegalovirus infections, exploring their impact on maternal and fetal health. Her work on SARS-CoV-2 epidemiology and immunology provides valuable insights into infection patterns, immunity development, and vaccine effectiveness. She is also engaged in the development of microfluidic diagnostic devices, integrating cutting-edge technology for rapid and precise pathogen detection. Additionally, her studies on Parvovirus B19 and Epstein-Barr virus contribute to the understanding of their clinical, molecular, and serological characteristics. Her expertise extends to respiratory tract virus surveillance, analyzing the spread and mutation patterns of viral infections to enhance public health strategies. By combining molecular techniques, serological analysis, and epidemiological insights, Dr. Uysal plays a crucial role in advancing infectious disease diagnostics and control.

Awards & Recognitions 🏆

Dr. Uysal has received recognition for her contributions to virology and molecular diagnostics. Her research on SARS-CoV-2 immunity, microfluidic diagnostic technologies, and viral infections in immunocompromised patients has been widely cited, reflecting her impact on global infectious disease research.

Publications 📚

Evaluation of Congenital Cytomegalovirus Infection in Pregnant Women (2024) – Viruses
DOI: 10.3390/v16030414 | Cited by: –

Fabrication of a Microfluidic Test Device for Streptococcus pyogenes Detection (2024) – Micromachines
DOI: 10.3390/mi15030365 | Cited by: –

Protection Against SARS-CoV-2 After Booster Vaccination (2024) – SSRN
DOI: 10.2139/ssrn.4777941 | Cited by: –

Role of Clinical, Molecular, and Serological Features in Parvovirus B19 Diagnosis (2024) – Diagnostic Microbiology and Infectious Disease
DOI: 10.1016/J.DIAGMICROBIO.2024.116300 | Cited by: –

Epstein-Barr Virus in Oral Lichen Planus & Contact Lesions (2024) – Northern Clinics of Istanbul
DOI: 10.14744/nci.2024.63239 | Cited by: –

Effect of COVID-19 Pandemic on Respiratory Viruses in Turkey (2024) – Infectious Disease Reports
DOI: 10.3390/idr16050079 | Cited by: –

Antibody Responses Post-Booster COVID-19 Vaccination (2024) – Diagnostic Microbiology and Infectious Disease
DOI: 10.1016/j.diagmicrobio.2024.116425 | Cited by: –

Evaluation of SARS-CoV-2-Positive Patients with Suspected Reinfection (2023) – Viruses
DOI: 10.3390/v15112222 | Cited by: –

Conclusion

Dr. Hayriye Kırkoyun Uysal’s research is groundbreaking, highly impactful, and aligns perfectly with the criteria for the Best Researcher Award. Her ability to address complex diagnostic and infectious disease challenges, along with her innovative research contributions, make her an excellent candidate for this award. Expanding her influence through broader international research collaborations could further amplify her impact on global healthcare.